Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.890
-0.050 (-2.58%)
At close: Mar 3, 2026, 4:00 PM EST
1.880
-0.010 (-0.52%)
Pre-market: Mar 4, 2026, 8:37 AM EST
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $129.21 million as of March 4, 2026. Its market cap has decreased by -41.11% in one year.
Market Cap
129.21M
Enterprise Value
71.74M
1-Year Change
-41.11%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $129.21M, an increase of 130.73%. That is a compound annual growth rate of 6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 129.20M | -31.75% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
| May 29, 2012 | 56.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 141.62M |
| Connect Biopharma Holdings | 139.76M |
| Adagene | 139.51M |
| Black Diamond Therapeutics | 138.45M |
| Immunic | 138.29M |
| Polaryx Therapeutics | 136.35M |
| Oramed Pharmaceuticals | 132.94M |
| Genelux | 129.31M |